Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002726025 | SCV003003962 | uncertain significance | not provided | 2023-05-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1962287). This variant has not been reported in the literature in individuals affected with CDAN1-related conditions. This variant is present in population databases (rs370515022, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 572 of the CDAN1 protein (p.Arg572Thr). |
Revvity Omics, |
RCV003492775 | SCV004234974 | uncertain significance | Anemia, congenital dyserythropoietic, type 1a | 2023-04-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004756414 | SCV005342186 | uncertain significance | CDAN1-related disorder | 2024-08-23 | no assertion criteria provided | clinical testing | The CDAN1 c.1715G>C variant is predicted to result in the amino acid substitution p.Arg572Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |